B Meidahl

Neuroleptic-induced tardive dyskinesia and parkinsonism: changes during several years of continuing treatment.

Casey De, Povlsen Uj, B Meidahl et al. · PubMed · 1986 · 40 citations

Neurological Disorder, Medicine, Parkinson Disease +7

An Early Clinical Phase II Evaluation of Paroxetine, a New Potent and Selective 5HT-Uptake Inhibitor in Patients with Depressive Illness

Carsten Børup, B Meidahl, Liselotte Petersen et al. · Pharmacopsychiatry · 1982 · 37 citations

Paroxetine and imipramine treatment of depressive patients in a controlled multicentre study with plasma amino acid measurements

Otto Anker Nielsen, Inger Morsing, J. Petersen et al. · Acta Psychiatrica Scandinavica · 1991 · 24 citations

Zuclopenthixol, a combined dopamine D1/D2 antagonist, versus haloperidol, a dopamine D2 antagonist, in tardive dyskinesia

Henrik Lublin, Jes Gerlach, U. Hagert et al. · European Neuropsychopharmacology · 1991 · 24 citations

Psychiatry, Medicine, Psychopharmacology +8

[The effects of neuroleptics on tardive dyskinesias. A video-controlled, randomized study of chlorprothixene, perphenazine, haloperidol and haloperidol + biperiden].

Povlsen Uj, Ulla Noring, B Meidahl et al. · PubMed · 1987 · 12 citations

Randomized Study, Tardive Dyskinesias, Medicine +5